These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 22020035)
1. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035 [TBL] [Abstract][Full Text] [Related]
2. A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats. Li L; Yun D; Zhang Y; Tao Y; Tan Q; Qiao F; Luo B; Liu Y; Fan R; Xian J; Yu A Brain Res; 2018 Oct; 1697():113-123. PubMed ID: 29886251 [TBL] [Abstract][Full Text] [Related]
3. CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice. Wu Q; Ma Y; Liu Y; Wang N; Zhao X; Wen D Life Sci; 2020 Nov; 260():118424. PubMed ID: 32949586 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery. Yang Y; Salayandia VM; Thompson JF; Yang LY; Estrada EY; Yang Y J Neuroinflammation; 2015 Feb; 12():26. PubMed ID: 25889169 [TBL] [Abstract][Full Text] [Related]
9. Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling. Ma L; Jia J; Liu X; Bai F; Wang Q; Xiong L Biochem Biophys Res Commun; 2015 Feb; 458(1):92-7. PubMed ID: 25637536 [TBL] [Abstract][Full Text] [Related]
10. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease. Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279 [TBL] [Abstract][Full Text] [Related]
11. Caffeic acid ester fraction from Erigeron breviscapus inhibits microglial activation and provides neuroprotection. Wang SX; Guo H; Hu LM; Liu YN; Wang YF; Kang LY; Gao XM Chin J Integr Med; 2012 Jun; 18(6):437-44. PubMed ID: 22821656 [TBL] [Abstract][Full Text] [Related]
12. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. Fernández-López D; Faustino J; Derugin N; Wendland M; Lizasoain I; Moro MA; Vexler ZS Neuroscience; 2012 Apr; 207():307-15. PubMed ID: 22285309 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model. Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355 [TBL] [Abstract][Full Text] [Related]
14. Time-Dependent Protection of CB2 Receptor Agonist in Stroke. Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541 [TBL] [Abstract][Full Text] [Related]
15. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Ward SJ; Castelli F; Reichenbach ZW; Tuma RF Life Sci; 2018 Feb; 195():1-5. PubMed ID: 29288767 [TBL] [Abstract][Full Text] [Related]
16. CB2R activation ameliorates late adolescent chronic alcohol exposure-induced anxiety-like behaviors during withdrawal by preventing morphological changes and suppressing NLRP3 inflammasome activation in prefrontal cortex microglia in mice. Li J; Wang H; Liu D; Li X; He L; Pan J; Shen Q; Peng Y Brain Behav Immun; 2023 May; 110():60-79. PubMed ID: 36754245 [TBL] [Abstract][Full Text] [Related]
17. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Clausen BH; Lambertsen KL; Meldgaard M; Finsen B Neuroscience; 2005; 132(4):879-92. PubMed ID: 15857694 [TBL] [Abstract][Full Text] [Related]
18. Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice. Poittevin M; Deroide N; Azibani F; Delcayre C; Giannesini C; Levy BI; Pocard M; Kubis N J Neuroimmunol; 2013 Jan; 254(1-2):55-62. PubMed ID: 23026222 [TBL] [Abstract][Full Text] [Related]
19. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Lambertsen KL; Clausen BH; Fenger C; Wulf H; Owens T; Dagnaes-Hansen F; Meldgaard M; Finsen B Neuroscience; 2007 Feb; 144(3):934-49. PubMed ID: 17161916 [TBL] [Abstract][Full Text] [Related]
20. A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats. Li L; Tao Y; Tang J; Chen Q; Yang Y; Feng Z; Chen Y; Yang L; Yang Y; Zhu G; Feng H; Chen Z Transl Stroke Res; 2015 Dec; 6(6):467-77. PubMed ID: 26376816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]